Randall Michael Giuffre is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 364,551 shares of DMAC, which is worth approximately $1.47 Million. The most recent transaction as insider was on Jan 02, 2024, when has been sold 19,196 shares (Voting Common Shares, no par value per share) at a price of $2.8 per share, resulting in proceeds of $53,748. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 365K
0% 3M change
5.56% 12M change
Total Value Held $1.47 Million

Randall Michael Giuffre Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2024
BUY
Grant, award, or other acquisition
$53,748 $2.8 p/Share
19,196 Added 5.0%
364,551 Voting Common Shares, ...
Jun 23 2023
SELL
Bona fide gift
-
15,000 Reduced 4.16%
345,355 Voting Common Shares, ...
Jun 23 2023
BUY
Open market or private purchase
$254,150 $3.91 p/Share
65,000 Added 15.28%
360,355 Voting Common Shares, ...
Jan 03 2023
BUY
Grant, award, or other acquisition
$53,748 $1.53 p/Share
35,130 Added 10.63%
295,355 Voting Common Shares, ...
Dec 09 2022
BUY
Open market or private purchase
$53,022 $1.43 p/Share
37,079 Added 12.47%
260,225 Voting Common Shares, ...
Dec 08 2022
BUY
Open market or private purchase
$28,000 $1.4 p/Share
20,000 Added 8.23%
223,146 Voting Common Shares, ...
Dec 07 2022
BUY
Open market or private purchase
$31,603 $1.4 p/Share
22,574 Added 10.0%
203,146 Voting Common Shares, ...
Dec 06 2022
BUY
Open market or private purchase
$3,105 $1.35 p/Share
2,300 Added 1.26%
180,572 Voting Common Shares, ...
Dec 01 2022
BUY
Open market or private purchase
$974 $1.19 p/Share
819 Added 0.46%
178,272 Voting Common Shares, ...
Dec 01 2022
BUY
Open market or private purchase
$55,359 $1.2 p/Share
46,133 Added 20.63%
177,453 Voting Common Shares, ...
Nov 30 2022
BUY
Open market or private purchase
$3,534 $1.19 p/Share
2,970 Added 2.21%
131,320 Voting Common Shares, ...
Nov 29 2022
BUY
Open market or private purchase
$21,568 $1.19 p/Share
18,125 Added 12.37%
128,350 Voting Common Shares, ...
Jan 03 2022
BUY
Grant, award, or other acquisition
$53,793 $3.58 p/Share
15,026 Added 12.0%
110,225 Voting Common Shares, ...
Jan 01 2021
BUY
Grant, award, or other acquisition
$61,239 $8.23 p/Share
7,441 Added 6.03%
116,029 Voting Common Shares, ...
Nov 20 2020
BUY
Open market or private purchase
$63,900 $4.26 p/Share
15,000 Added 12.14%
108,588 Voting Common Shares, ...
RMG

Randall Michael Giuffre

Director
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Track Activities on DMAC